Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cells.

Literature DB >> 28251140

MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cells.

Pavlina Krasimirova Todorova¹, Bipasha Mukherjee¹, Sandeep Burma¹.

Abstract

Entities: Disease

Year: 2017 PMID： 28251140 PMCID： PMC5326644 DOI： 10.21037/atm.2017.01.67

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

29 in total

1. Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor.

Authors: Andrew S Chi; Tracy T Batchelor; Eunice L Kwak; Jeffrey W Clark; Daphne L Wang; Keith D Wilner; David N Louis; A John Iafrate
Journal: J Clin Oncol Date: 2011-12-12 Impact factor: 44.544

Review 2. Targeting MET in cancer: rationale and progress.

Authors: Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal: Nat Rev Cancer Date: 2012-01-24 Impact factor: 60.716

3. The somatic genomic landscape of glioblastoma.

Authors: Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal: Cell Date: 2013-10-10 Impact factor: 41.582

4. The MET oncogene is a functional marker of a glioblastoma stem cell subtype.

Authors: Francesca De Bacco; Elena Casanova; Enzo Medico; Serena Pellegatta; Francesca Orzan; Raffaella Albano; Paolo Luraghi; Gigliola Reato; Antonio D'Ambrosio; Paola Porrati; Monica Patanè; Emanuela Maderna; Bianca Pollo; Paolo M Comoglio; Gaetano Finocchiaro; Carla Boccaccio
Journal: Cancer Res Date: 2012-06-26 Impact factor: 12.701

Review 5. DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance.

Authors: Massimo Squatrito; Eric C Holland
Journal: Cancer Res Date: 2011-09-13 Impact factor: 12.701

6. MET signaling regulates glioblastoma stem cells.

Authors: Kyeung Min Joo; Juyoun Jin; Eunhee Kim; Kang Ho Kim; Yonghyun Kim; Bong Gu Kang; Youn-Jung Kang; Justin D Lathia; Kwang Ho Cheong; Paul H Song; Hyunggee Kim; Ho Jun Seol; Doo-Sik Kong; Jung-Il Lee; Jeremy N Rich; Jeongwu Lee; Do-Hyun Nam
Journal: Cancer Res Date: 2012-05-22 Impact factor: 12.701

7. Spatiotemporal Evolution of the Primary Glioblastoma Genome.

Authors: Jinkuk Kim; In-Hee Lee; Hee Jin Cho; Chul-Kee Park; Yang-Soon Jung; Yanghee Kim; So Hee Nam; Byung Sup Kim; Mark D Johnson; Doo-Sik Kong; Ho Jun Seol; Jung-Il Lee; Kyeung Min Joo; Yeup Yoon; Woong-Yang Park; Jeongwu Lee; Peter J Park; Do-Hyun Nam
Journal: Cancer Cell Date: 2015-09-14 Impact factor: 31.743

8. MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.

Authors: Virna Cepero; J Rafael Sierra; Simona Corso; Elena Ghiso; Laura Casorzo; Tim Perera; Paolo Maria Comoglio; Silvia Giordano
Journal: Cancer Res Date: 2010-09-14 Impact factor: 12.701

9. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors: Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal: Lancet Oncol Date: 2009-03-09 Impact factor: 41.316

10. MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.

Authors: Francesca De Bacco; Antonio D'Ambrosio; Elena Casanova; Francesca Orzan; Roberta Neggia; Raffaella Albano; Federica Verginelli; Manuela Cominelli; Pietro L Poliani; Paolo Luraghi; Gigliola Reato; Serena Pellegatta; Gaetano Finocchiaro; Timothy Perera; Elisabetta Garibaldi; Pietro Gabriele; Paolo M Comoglio; Carla Boccaccio
Journal: EMBO Mol Med Date: 2016-05-02 Impact factor: 12.137

3 in total

Review 1. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.

Authors: Karina Biserova; Arvids Jakovlevs; Romans Uljanovs; Ilze Strumfa
Journal: Cells Date: 2021-03-11 Impact factor: 6.600

Review 2. Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion.

Authors: Alison Roos; Zonghui Ding; Joseph C Loftus; Nhan L Tran
Journal: Front Oncol Date: 2017-06-16 Impact factor: 6.244

3. H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.

Authors: Wenyan Zhang; Rui Duan; Jian Zhang; William K C Cheung; Xiaoge Gao; Raymond Zhang; Qing Zhang; Mengxue Wei; Gang Wang; Qian Zhang; Peng-Jin Mei; Hong-Lin Chen; Hsiangfu Kung; Marie C Lin; Zan Shen; Junnian Zheng; Longzhen Zhang; Hong Yao
Journal: Br J Cancer Date: 2018-01-18 Impact factor: 7.640

3 in total